Jump to page content

Michael Schmück-Henneresse

  • Develop T-cell-based solutions for protection against viral infections, autoimmune diseases, and cancer, aiming to create safe and effective T-cell products for new treatment options.
  • Enhance and reactivate T-cell activity in tumors and organ transplantation.
  • Develop technologies to detect, characterize, and reprogram T-cell specificity.
  • Utilize gene-editing to boost T-cell activity, migration, and resistance to immunosuppression.
  • Prevent immunopathologies associated with genetic modifications, including those using CRISPR-Cas.
  • Create testing platforms, including patient-derived organoid models and 3D cultures.
  • Employ advanced techniques such as imaging, spectral flow cytometry, proteomics, and scRNA-seq.

Akkordeon